Synaptive Medical introduces new surgical robotic device

October 11, 2017  Source: medicaldevice-network 536

Canadian firm Synaptive Medical has introduced its second-generation, high-powered Modus V digital microscope that has a robotic arm to aid neurosurgery.

Modus V is based on Canadarm technology used at the International Space Station and is part of the firm’s integrated BrightMatter platform.

The new device is intended to allow an enhanced view of patient anatomy, which enables surgeons to perform accurate and less invasive procedures, leading to fast recovery times and decreased complications.

With advanced instrument tracking and auto-focus, the device facilitates hands-free control and increased surgical efficiency.

Synaptive Medical CEO Peter Wehrly said: “Modus V is an integral part of our overall BrightMatter surgical solution.

"Conceptualised for the digital era as a fully integrated set of devices, our solution collects and delivers data - be it imaging, tractography or other patient information - when and where it’s most needed to drive surgical decision making.

"It’s part of our ongoing commitment to give surgeons the most advanced tools with which to treat their patients."

“It’s part of our ongoing commitment to give surgeons the most advanced tools with which to treat their patients.”

BrightMatter is designed to provide a fully integrated platform for surgical planning, patient data collection, and intraoperative vision through navigation, robotic automation, digital microscopy, and data analytics.

Synaptive Medical president and chief strategy officer Cameron Piron said: “Modus V’s improvements are grounded in the collaboration and extensive feedback from neurosurgeons in our customer community on both Modus V prototypes and BrightMatter Drive.”

The device features improved flexibility to allow coverage of more space and versatile positioning, while its smaller unit footprint enables rapid deployment.

By Ddu
Share: 

your submission has already been received.

OK

Subscribe

Please enter a valid Email address!

Submit

The most relevant industry news & insight will be sent to you every two weeks.